3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Lennox Gastaut Syndrome
1
Glioblastoma
1
Epilepsy
1
Epilepsies, Myoclonic
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Breast Neoplasms
1
Arthralgia
1
Anxiety Disorders
1
Interventions
Oxycodone
5
Morphine
5
nabiximols
4
Naloxone
2
Fentanyl
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
naloxegol
1
incobotulinumtoxinA
1
Water
1
Transcranial Direct Current Stimulation
1
Tapentadol
1
Sodium Bicarbonate
1
Methadone
1
Lidocaine
1
Lenalidomide
1
Ketamine
1
Inosine Monophosphate
1
Hydromorphone
1
Glucose
1
Donepezil
1
Cognitive Behavioral Therapy
1
Buprenorphine
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cancer Pain
×
Cannabidiol
×
Clear all
No trials found.